Pathogenic superoxide dismutase structure, folding, aggregation and turnover
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive destruction of motor neurons. Approximately 10% of cases are inherited and are termed ‘familial’ (fALS). A subset of these cases are linked to dominant mutations in the cytosolic antioxidant enzyme copper-zinc superoxide dismutase (SOD1) [1, 2]. Mice expressing human fALS SOD1 polypeptides in addition to their endogenous SOD1 develop paralytic symptoms, whereas SOD1 knockout mice do not [3, 4]. SOD1-linked ALS is thus not a loss-of-function disorder, as the expression of the mutant SOD1 polypeptides is sufficient to cause motor neuron death through an as-yet unidentified molecular mechanism. The mouse models have provided a clue, however, in that aggregates containing pathogenic SOD1 become manifest in the motor neurons of animals exhibiting paralytic symptoms [3]. It is now generally accepted that pathogenic SOD1 aggregation is linked to toxicity. This review focuses on the advances since 2003 that have shaped our understanding of the molecular and biophysical properties of the fALS SOD1 mutants in the context of protein structure, misfolding, aggregation and turnover. Studies aimed at developing therapies or prolonging the lifespan of transgenic animals are not covered. Two excellent recent comprehensive reviews of the link between SOD1 and ALS can be found in [5, 6].
Section snippets
Spatial distribution and classification of pathogenic SOD1 mutations
Human SOD1 is a 32 kDa homodimeric protein found in the cytosol, nucleus and intermembrane space of mitochondria [5]. Each monomer folds as an eight-stranded Greek key β-barrel, binds one copper and one zinc ion, and contains an intrasubunit disulfide bond. Approximately 110 fALS mutations have now been identified. The majority of lesions give rise to point mutations, but a few result in truncations or amino acid insertions/deletions. The fALS SOD1 proteins are divided into two groups on the
Structures of pathogenic SOD1 mutants
Three-dimensional structures have been published for the metal-replete WTL mutants A4V [8•, 9], G37R [10], H43R [11], G93A [12] and I113T [8•]. They are all similar to the wild-type protein except for perturbations at or near the site of mutation. The A4V and I113T structures reveal a slight reorientation of the monomers relative to the wild-type enzyme [8•]. Solution small-angle X-ray scattering studies suggest that this reorientation may be more pronounced than that observed in the crystal,
SOD1 folding and quaternary structure
Human SOD1 is a remarkably stable dimeric molecule that remains active under a broad range of harsh denaturing conditions. The intrasubunit disulfide bond formed between Cys57 and Cys146 in each monomer is a rare feature for a protein found in the reducing environment of the cytosol. Although the stabilizing effect of metal ions has long been known, a recent series of studies on the wild-type enzyme have shed light on the structural and functional role of this unusual disulfide [20•, 21•, 22•].
Pathogenic SOD1 aggregation
Studies of pathogenic SOD1 aggregation in vitro are now beginning to appear. The mutants A4V and H43R can form filamentous aggregates that bind Congo red [11]. Khare and colleagues proposed that SOD1 aggregation is a multistep reaction consisting of dimer dissociation, metal loss from the monomers, followed by oligomerization. They also calculated rate and equilibrium constants for the dissociation event [31]. In both studies mentioned above, the experimental conditions were non-native (pH
Pathogenic SOD1 and molecular chaperones
The propensity of pathogenic SOD1 to aggregate in vivo is linked to its concentration, the ability of molecular chaperones to prevent or reverse misfolding, and the rate of turnover by the protein degradation machinery. In presymptomatic G85R and G93A mice, a reduction in total chaperone activity was observed beginning at 60 days of age [42]. However, the small chaperones Hsp25 (Hsp27 in humans) and αβ-crystallin were shown to be upregulated in astrocytes (but not motor neurons) of symptomatic
Pathogenic SOD1 and the proteasome
Studies focused on degradation of pathogenic SOD1 proteins by the proteasome are in their infancy. Two groups demonstrated that the co-chaperone CHIP (C-terminus of Hsc70-interacting protein) associates with mutant SOD1 and promotes its degradation by the ubiquitin-proteasome system [46, 47]. The ubiquitin ligase NEDL1 was shown to bind and ubiquitinate fALS mutants but not wild-type SOD1 [48]. Proteasome inhibition resulted in aggregation in spinal cord slices of G93A mice and subsequent
Conclusions
Figure 4 reflects a summary of current thinking on pathogenic SOD1 aggregation, turnover and toxicity. With few exceptions, the fALS mutations destabilize the structure through metal ion loss or perturbations of the protein fold, and these destabilized SOD1 proteins either aggregate or are turned over rapidly when compared with the wild-type enzyme. It remains unclear exactly how the soluble oligomers, the insoluble aggregates, or the proteolytic breakdown products of pathogenic SOD1 are toxic,
Update
Recently, protein components of secretory large dense-core vesicles in neurons, interneurons and endocrine cells, were found to interact with pathogenic SOD1 proteins, but not with the wild-type enzyme [56••]. These proteins, termed chromogranins, are moved though the trans-Golgi network, translocating to the cell periphery during the maturation process. Data are presented that suggest that chromogranins may act as chaperone-like proteins to facilitate secretion of misfolded SOD1 mutants that
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
I thank members of the Borchelt, Hart, Hayward, Hasnain, Levine and Valentine laboratories for their many helpful discussions and insights, and Stephen Holloway and Alex Taylor for help with the figures. I also thank David Eisenberg, Jon Robertus and Joan Valentine for their guidance and friendship over the years. Work on SOD1 in my laboratory has been supported at various times by the NIH/NINDS, the ALS Association, and the Robert A Welch Foundation. Support for the X-ray Crystallography Core
References (56)
- et al.
ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
Neuron
(1997) - et al.
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis
J Biol Chem
(2002) - et al.
Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis
Protein Sci
(1998) - et al.
Dynamic properties of the G93A mutant of copper-zinc superoxide dismutase as detected by NMR spectroscopy: implications for the pathology of familial amyotrophic lateral sclerosis
Biochemistry
(2003) - et al.
Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site
Neurobiol Dis
(2002) - et al.
Cu/Zn superoxide dismutase can form pore-like structures
Biochem Biophys Res Commun
(2003) - et al.
An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis
Biochemistry
(2004) - et al.
The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status
J Biol Chem
(2004) - et al.
Dissociation of human copper-zinc superoxide dismutase dimers using chaotrope and reductant. Insights into the molecular basis for dimer stability
J Biol Chem
(2004) - et al.
Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction
J Biol Chem
(2003)
Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants
Proc Natl Acad Sci USA
Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis
J Biol Chem
Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation
Proc Natl Acad Sci USA
Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation
Hum Mol Genet
Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice
J Neurosci
CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70
J Neurochem
Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes
J Neurochem
Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates
J Cell Biol
Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome
J Biol Chem
Truncated wild-type SOD1 and FALS-linked mutant SOD1 cause neural cell death in the chick embryo spinal cord
Neurobiol Dis
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase
Science
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Nature
Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
Nat Genet
Unraveling the mechanisms involved in motor neuron degeneration in ALS
Annu Rev Neurosci
Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis
Annu Rev Biochem
Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants
Proc Natl Acad Sci USA
Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase
J Mol Biol
ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization
J Mol Biol
Cited by (93)
Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase
2015, Journal of Biological ChemistryCitation Excerpt :Dimer destabilization was also proposed to be a key part of the SOD1-linked ALS disease mechanism based on the fact that the crystal structure of a FALS mutant, A4V, with properties similar to those of WT hSOD1, showed noticeable alterations of the dimer interface despite the absence of significant changes in the individual monomer structure (57). Subsequently, it was demonstrated that dissociated monomeric hSOD1 was an intermediate in aggregation formation and also a good substrate for 20 S proteasome (58, 59). Besides the monomeric form of hSOD1, exposed Cys residues from disulfide reduction appeared to be involved in aggregation through disulfide-cross-linked multimerization (14, 60–62).
Copper mediated neurological disorder: Visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease
2015, Journal of Trace Elements in Medicine and BiologyBioinorganic Neurochemistry
2013, Comprehensive Inorganic Chemistry II (Second Edition): From Elements to ApplicationsHDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation
2013, Journal of Biological ChemistryCitation Excerpt :We conclude that elevated levels of tubulin acetylation, as mimicked by the expression of the K40Q mutant α-tubulin, enhanced mutant SOD1 aggregation. The familial ALS mutants of SOD1 are prone to aggregation, and the cytoplasmic inclusions are characteristic in relevant human patients as well as disease model systems (3, 4, 7–10). HDAC6 has been shown to regulate the formation of poly-ubiquitin-positive inclusions (16), but its role in mutant SOD1 aggregation has not yet been reported yet.